Background Previous studies have suggested that moderate alcoholintake exerts a protective effect against coronary heart disease.Alterations in plasma lipoprotein levels represent one plausiblemechanism of this apparent protective effect.
Methods We therefore examined the interrelation among alcoholconsumption, plasma lipoprotein levels, and the risk of myocardialinfarction in 340 patients who had had myocardial infarctionsand an equal number of age- and sex-matched controls. The casepatients were men or women less than 76 years of age with nohistory of coronary disease who were discharged from one ofsix hospitals in the Boston area with a diagnosis of a confirmedmyocardial infarction. Alcohol consumption was estimated bymeans of a food-frequency questionnaire.
Results We observed a significant inverse association betweenalcohol consumption and the risk of myocardial infarction (Pfor trend, <0.001 after control for known coronary risk factors).In multivariate analyses, the relative risk for the highestintake category (subjects who consumed three or more drinksper day) as compared with the lowest (those who had less thanone drink a month) was 0.45 (95 percent confidence interval,0.26 to 0.80). The levels of total high-density lipoproteincholesterol (HDL) and its HDL2 and HDL3 subfractions were stronglyassociated with alcohol consumption (P for trend, <0.001for each). The addition of HDL or either of its subfractionsto the multivariate model substantially reduced the inverseassociation between alcohol intake and myocardial infarction,whereas the addition of the other plasma lipid measurementsdid not materially alter the relation.
Conclusions These data confirm the inverse association of moderatealcohol intake with the risk of myocardial infarction and supportthe view that the effect is mediated, in large part, by increasesin both HDL2 and HDL3.
The effects of alcohol consumption on cardiovascular diseaseare complex. Although heavy alcohol intake increases overallmortality1,2,3,4 and mortality due to cardiovascular diseases,3,4,5,6moderate intake appears to exert a protective effect againstcoronary heart disease, as compared with drinking no alcohol7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22.
The mechanisms by which moderate alcohol intake exerts thisprotective effect are not well understood. Alcohol intake raisesthe levels of high-density lipoprotein cholesterol (HDL),23,24,25,26,27,28,29a fact that may explain, at least in part, its apparent protectiveeffect against coronary heart disease30,31,32,33. However, previousstudies with small numbers of subjects have had apparently inconsistentfindings with respect to relations among alcohol, HDL levels,and myocardial infarction. Specifically, when subfractions ofHDL were examined, the inverse relation between the HDL2 subfractionand the risk of myocardial infarction was clearly demonstrated,whereas the data on the role of HDL3 were less consistent34,35,36.Moreover, evidence from small studies appeared to indicate thatmoderate alcohol consumption raised the level of HDL3 but notHDL237,38,39. More recently, in data from both the present case-controlstudy40 and a prospective cohort study,41 the levels of bothsubfractions have been shown to be independent predictors ofmyocardial infarction. In this case-control study, we examinedthe extent to which plasma lipoprotein levels, including thoseof HDL and its subfractions, mediate the relation between alcoholconsumption and the risk of myocardial infarction.
Methods
We reviewed all admissions between January 1, 1982, and December31, 1983, to the coronary care units and other intensive careunits of six suburban Boston hospitals (Emerson Hospital, FraminghamUnion Hospital, Leonard Morse Hospital, Mount Auburn Hospital,Newton-Wellesley Hospital, and Waltham-Weston Hospital) to identifyeligible patients. Those eligible for inclusion were white menor women less than 76 years of age who lived in the Boston areaand had no history of previous myocardial infarction or anginapectoris, in whom symptoms of myocardial infarction had begunduring the 24 hours before admission. Patients with a diagnosisof confirmed myocardial infarction, based on the clinical historyand an increased creatine kinase concentration, who were dischargedalive were enrolled in the study if they were willing and ableto participate and if informed consent could be obtained fromboth the patient and the admitting physician. The research protocolwas approved by the institutional human-subjects committeesof all the participating hospitals.
For each case patient, a control was chosen at random from thelist of residents of the town in which the patient lived. Morespecifically, the name of the case patient was located in theappropriate residence list of the town where the case patientlived, and the next resident of the same sex and age (withinfive years) who had a listed telephone number was selected asa control. Potentially eligible subjects were sent letters ofinvitation and then contacted by telephone. Of the eligiblesubjects contacted, 84 percent of the case patients and 60 percentof the controls were enrolled, yielding a total of 340 case-controlpairs.
All case patients and controls were interviewed in their homes.The patients were interviewed approximately eight weeks aftermyocardial infarction. Information was collected on a wide varietyof potential coronary risk factors during the period beforethe myocardial infarction (for the case patients) and beforethe interview (for the controls). This information covered age,sex, hypertension, cigarette smoking, body-mass index, familyhistory of premature myocardial infarction (at less than 60years of age), dietary intake, psychological variables, socioeconomicstatus, level of physical activity, and alcohol consumption.Information on diet and alcohol consumption was gathered bymeans of a semiquantitative food-frequency questionnaire42,43.Psychological variables were measured with the use of 18 questionsfrom the Framingham Heart Study (10 assessing type A behavior,7 assessing anger, and 1 regarding the number of promotionsover the past 10 years)44. Information on socioeconomic statusincluded the subject's usual occupation and his or her educationallevel. Fasting venous blood samples were obtained and analyzedfor lipids, including total HDL cholesterol and its HDL2 andHDL3 subfractions.
Total daily intake of alcohol was estimated on the basis ofinformation about the consumption of beer, wine, and liquorduring the year before the myocardial infarction, for the casepatients, and the year before the interview, for the controls.Daily intake was estimated in grams according to the averagenumber of grams of ethanol in a serving of each type of alcoholicbeverage (beer, 13.2 g; wine, 10.8 g; liquor, 15.1 g). Totaldaily intake was then converted into the number of drinks perday by dividing the total daily consumption in grams by 13.2g per drink (the ethanol content of one serving of beer). Fourcategories of alcohol intake were defined: less than one drinkper month, one or more drinks per month but less than one perday, one or more drinks per day but less than three per day,and three or more drinks per day. Although the fourth categoryincluded heavy drinkers (defined as those with an average dailyconsumption of five or more drinks per day), there were relativelyfew such subjects (n = 38).
Fasting venous blood was drawn into tubes containing 0.1 percentEDTA, and plasma was obtained by centrifugation at 3000 rpmfor 30 minutes at 4 °C. Fresh plasma was used to determinethe levels of total cholesterol, HDL, low-density lipoproteincholesterol (LDL), very-low-density lipoprotein cholesterol(VLDL), and triglycerides by the methods of the Lipid ResearchClinics45,46,47. Cholesterol determinations were standardizedwith the Lipid Standardization Program of the Centers for DiseaseControl and Prevention. HDL subfractions were measured in fresh,unfrozen plasma from a subgroup of 558 subjects (283 case patientsand 275 controls) by the dextran sulfate method of Gidez etal48. Apolipoproteins A-I, A-II, B, and E were measured withspecific radioimmunoassays in samples from a total of 346 subjects(206 case patients and 140 controls)49,50,51,52. Plasma samplesfor apolipoprotein analyses had been stored at -70 °C forless than one year, with virtually identical storage times forthose from case patients and controls.
Matched-pair and crude unmatched relative risks were calculated53.Since these were virtually identical, we judged that the matchingcould safely be disregarded and thereafter performed unmatchedanalyses. Although the results of our analyses with and withoutformer drinkers were not materially different, many subjectswho had recently stopped drinking may have been heavy consumersin the past, so the 19 subjects who reported ceasing alcoholconsumption within the past two years were excluded. Relativerisks were calculated for each of the three highest categoriesof alcohol consumption as compared with the lowest intake category.
Multiple logistic-regression analyses were used to estimaterelative risks, with simultaneous control for a number of coronaryrisk factors54. Logistic regression was used in tests for trend.To determine the degree to which the levels of various lipidsmediated any effect of alcohol, the levels of total cholesterol,LDL, triglycerides, VLDL, HDL, HDL2, HDL3, and the ratio ofHDL2 to HDL3 were added to the risk-factor model one at a time.Logistic-regression models were compared with the likelihood-ratiotest. Similarly, we added the levels of apolipoproteins A-I,A-II, B, and E sequentially to a model containing the coronaryrisk factors and total HDL in order to determine the degreeto which apolipoproteins mediate the effect of alcohol, beyondthe effect of HDL.
Results
Base-line characteristics of the case patients and controlsare shown in Table 1. The coronary risk factors for each drinkingcategory among the controls are shown in Table 2. The heavierdrinkers were more likely to be men, to smoke cigarettes, toengage in physical activity, and to have a higher total caloricintake and were less likely to have diabetes.
Table 2. Coronary Risk Factors among the Controls, According to Alcohol Consumption.
Adjusted relative risks for each intake category, as comparedwith the reference category, are shown in Table 3. The relativerisks of myocardial infarction, adjusted for age and sex, weresignificantly reduced in the two highest alcohol-consumptioncategories. Specifically, the relative risk was 0.50 (95 percentconfidence interval, 0.33 to 0.78) among those who consumedmore than one but fewer than three drinks per day and 0.49 (95percent confidence interval, 0.29 to 0.81) among those who consumedthree or more drinks per day. The test for trend across alcohol-consumptioncategories was highly significant (P for trend, <0.001).Controlling for coronary risk factors in the logistic-regressionanalyses did not materially alter the results. Lipoprotein levelsand complete data on risk factors were available for 541 subjects,after subjects who had recently stopped drinking were excluded.The results in this subgroup did not differ materially fromthose of the full model.
Table 3. Relative Risk of Myocardial Infarction, According to Alcohol Consumption.
The relations between alcohol consumption and lipoprotein levelsare shown in Table 4. Total HDL, as well as both HDL2 and HDL3,were strongly associated with alcohol consumption, whereas nosuch relation was apparent for total cholesterol, LDL, VLDL,or triglycerides. To determine the extent to which the reducedrisk of myocardial infarction was mediated by lipids, each lipoproteinmeasurement was added individually to the risk-factor model.The addition of the total cholesterol, LDL, VLDL, and triglyceridelevels did not substantially alter the relation between alcoholand myocardial infarction (Table 5). However, the apparent reductionsin risk in the two highest categories for alcohol intake weresubstantially attenuated by the addition of total HDL, HDL2,HDL3, or both HDL2 and HDL3 to the model. Each subfraction appearedto have an independent attenuating effect. Thus, the apparentprotective effect of moderate alcohol consumption appeared tobe mediated, in large part, by both the HDL2 and HDL3 subfractions.
Table 5. Adjusted Relative Risk of Myocardial Infarction among Subjects Whose Lipid Levels Were Measured, According to Alcohol Consumption.
Apolipoproteins A-I and A-II were also positively associatedwith alcohol consumption (P for trend, <0.001 for both A-Iand A-II), whereas there was no such relation for apolipoproteinsB and E. To determine whether the apparent risk reduction associatedwith moderate alcohol intake was further mediated by apolipoproteinlevels, we added each apolipoprotein to the risk-factor modelalong with total HDL; adding the HDL2 or HDL3 subfraction didnot significantly improve the model that included total HDL,according to the log-likelihood-ratio test (chi-square withone degree of freedom = 1.52, P = 0.22). The addition of apolipoproteinsA-I and A-II did significantly improve the model and appearedto further attenuate the effect of alcohol consumption in thehighest intake category. However, the sample size (n = 337)was relatively small, and the wide confidence intervals makethese findings difficult to interpret. Specifically, the relativerisk, adjusted for risk factors and the total HDL level, amongsubjects in the highest intake category as compared with thosein the lowest changed from 0.85 (95 percent confidence interval,0.35 to 2.05) to 0.94 (95 percent confidence interval, 0.38to 2.33) after the addition of apolipoprotein A-I and to 1.08(95 percent confidence interval, 0.42 to 2.77) after the additionof apolipoprotein A-II to the model. The addition of apolipoproteinB or apolipoprotein E did not materially alter the relation.
Discussion
These data indicate a significant inverse relation between alcoholconsumption and the risk of myocardial infarction, even afterthe effects of other coronary risk factors have been taken intoaccount. In addition, we found that alcohol consumption wasassociated with increased levels of HDL2 and HDL3, and thatboth subfractions were associated with decreased risks of myocardialinfarction40. Thus, these data suggest a beneficial effect ofalcohol consumption on the risk of myocardial infarction thatis mediated in large part by alterations in lipoprotein levels-- in particular, by increases in both HDL subfractions. Therewas also a suggestion that the beneficial effect might be furthermediated by increases in the levels of apolipoprotein A-I andA-II, but our data were insufficient to confirm this relation.Other potential contributing mechanisms, including alterationsin hemostasis, could not be evaluated in this study.
A consistent body of evidence now supports the hypothesis thatmoderate alcohol intake reduces the risk of coronary heart disease8,9,10,11,12,13,14,15,16,22.Shaper et al. have suggested that the inverse association isdue to the contamination of the nondrinking category with subjectswho have reduced their drinking because of existing coronaryheart disease55. However, this phenomenon would not explainthe apparent dose-response relation reported in most studies.In our study, none of the case patients or controls were knownto have preexisting coronary heart disease, and former drinkerswho had recently stopped drinking were excluded from the analyses,so it is unlikely that this potential source of bias had anyeffect on our results. A U-shaped relation between alcohol consumptionand coronary heart disease has been reported, with the lowestrisks observed among moderate drinkers and the highest risksamong heavy drinkers (defined as those consuming five or morealcoholic drinks per day)17,18,19,20. However, the current populationdid not include enough heavy drinkers for us to assess adequatelythe risk among heavy drinkers.
The evidence from both observational studies24,25,26,27,28,29,56and experimental trials28,29 suggests that alcohol raises thelevel of total HDL, and that approximately 50 percent of thereduction in risk attributable to alcohol consumption is explainedby the changes in total HDL26,27. The effect of alcohol consumptionon the HDL subfractions is far less consistent; short-term trials39and observational data37,38 among moderate drinkers supportan association only with HDL3, whereas studies among alcoholicsubjects have found evidence of increases in both subfractions57,58,59,60,61.Our study provides strong support for the hypothesis that levelsof both HDL2 and HDL3 are increased by alcohol consumption andthat increases in each subfraction decrease the risk of myocardialinfarction. The apparent discrepancies among the reported resultsmay reflect separate mechanisms for alcohol-induced alterationsin each subfraction, though speculation about the specific mechanismsare beyond the scope of our study. With regard to apolipoproteins,increases in both A-I and A-II have been consistently associatedwith moderate alcohol intake, as demonstrated in our study37,62,63,64.However, the degree to which the protective effect of alcoholis mediated by apolipoproteins A-I and A-II, beyond the effectof HDL, remains unclear.
Several limitations should be considered in interpreting theseresults. First, only survivors of myocardial infarction wereincluded in this study because of our need to obtain informationon a large number of lifestyle variables as well as to allowtransient alterations in lipoprotein levels to return to normalbefore plasma samples were obtained. As a result, we have probablyunderestimated the effect of many coronary risk factors becauseof our selection of the healthiest patients with myocardialinfarction.
Second, although the choice of neighborhood rather than hospitalcontrols had the advantage of providing a comparison group morelikely to have come from the same population as the case patients,there was, as expected, a higher response rate among case patientsthan among controls. Nonresponse could, in theory, have biasedour results, yet it seems unlikely that this occurred to anyappreciable degree. The response rate among the controls variedamong the neighborhoods of the six hospitals, and the observedassociations were not appreciably different between those withhigher response rates and those with lower rates. Furthermore,our results for other well-documented cardiovascular risk factorswere consistent with those observed in previous studies.
With respect to potential confounding, one of the strengthsof this study is that we were able to collect information ona wide variety of potential coronary risk factors, includingdemographic characteristics, medical history, and behavioralvariables. Although it is possible that residual confoundingby unmeasured factors could have affected the results, it isunlikely to have been extensive, since accounting for the largenumber of risk factors for which information was available didnot materially affect the results.
The timing of blood collection could have affected lipid levels,since myocardial infarction is known to affect lipid metabolismin the short term. For this reason, we used blood specimenscollected about eight weeks after hospital discharge, ratherthan samples drawn in the hospital. Several interventions aftermyocardial infarction may have altered lipid levels, includingdietary modifications, exercise, and treatment for elevatedcholesterol levels, as well as the use of beta-blockers or thiazidediuretics. Thus, confounding by the effects of interventionsafter myocardial infarction cannot be excluded. The overallresult of these interventions would probably have been onlyslight increases in HDL levels among the case patients. IncreasingHDL levels in the case patients would have caused us to underestimatethe true association between this lipoprotein and the risk ofmyocardial infarction and thus to minimize the attenuation ofthe alcohol effect by HDL levels. We could not control for drugtreatment or other interventions after myocardial infarctionsince the information collected from case patients covered theyear before the event, not the period after discharge. However,adjustment for previous treatment for elevated cholesterol levels,as well as for the use of beta-blocker and thiazide drugs, didnot materially alter the results.
The data on alcohol intake were collected for the year beforemyocardial infarction for the case patients, and changes inalcohol consumption after myocardial infarction could have affectedthe results. It is unlikely that subjects would have increasedtheir alcohol intake for health reasons in the early 1980s.Cessation of alcohol consumption after myocardial infarction,with a subsequent reduction in the HDL cholesterol level, wouldhave biased our results regarding the effect of HDL toward afinding of no effect. Furthermore, analyses were conducted inwhich subjects who reported stopping alcohol use within thepast two years were excluded; the results were not materiallydifferent.
In summary, this case-control study demonstrates a significantinverse association between alcohol consumption and the riskof myocardial infarction. Our results also strongly suggestthat the observed protective effect is mediated, in large part,by changes in HDL levels and more specifically by the levelsof both the HDL2 and HDL3 subfractions, although other contributingmechanisms of action have not been excluded. Although we judgethe association to be causal, any public health recommendationsor recommendations for individual patients must take into accountthe complexity of the metabolic, physiologic, and psychologicaleffects of alcohol. With alcohol, the differences between dailysmall-to-moderate amounts and large quantities may be the differencebetween preventing and causing disease. Finally, heavy alcoholconsumption is a leading avoidable cause of death in the UnitedStates. Thus, an important implication of these data, whichdemonstrate that the benefit of alcohol levels on myocardialinfarction is mediated in large part by increases in HDL, isthat further research should be directed to finding safer methodsof raising the level of this lipid.
Supported by research grants (HL-24423 and HL-21006) and aninstitutional training grant (HL-07575) from the National Heart,Lung, and Blood Institute.
We are indebted to the six hospitals in the Boston area thatparticipated in this study and to the respective collaborators:Emerson Hospital (Marvin H. Kendrick, M.D.), Framingham UnionHospital (Marvin Adner, M.D., and Gerald Evans, M.D.), LeonardMorse Hospital (L. Frederick Kaplan, M.D.), Mount Auburn Hospital(Leonard Zir, M.D.), Newton-Wellesley Hospital (James Sidd,M.D.), and Waltham-Weston Hospital (Solomon Gabbay, M.D.); weare also indebted to Peter Herbert and Conrad Blum for performingthe apolipoprotein analyses, and to Anne Cadigan for assistancein the preparation of the manuscript.
Source Information
From the Division of Preventive Medicine (J.M.G., J.E.B., M.V., C.H.H.), the Channing Laboratory (S.Z.G., B.R., W.W.), and the Cardiovascular Division (J.M.G., S.Z.G.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston; the Department of Ambulatory Care and Prevention, Harvard Medical School, Boston (J.E.B., C.H.H.); the Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston (W.W.); the Department of Medicine, Veterans Affairs Medical Center, West Roxbury, Mass. (J.M.G.); and the Laboratory of Biochemical Genetics and Metabolism, Rockefeller University, New York (J.L.B.).
Address reprint requests to Dr. Gaziano at Brigham and Women's Hospital, 900 Commonwealth Ave. East, Boston, MA 02215-1204.
References
Klatsky AL, Friedman GD, Siegelaub AB. Alcohol and mortality: a ten-year Kaiser-Permanente experience. Ann Intern Med 1981;95:139-145.
Pell S, D'Alonzo CA. A five-year mortality study of alcoholics. J Occup Med 1973;15:120-125. [Medline]
Rosengren A, Wilhelmsen L, Wedel H. Separate and combined effects of smoking and alcohol abuse in middle-aged men. Acta Med Scand 1988;223:111-118. [Medline]
Thorarinsson AA. Mortality among men alcoholics in Iceland, 1951-74. J Stud Alcohol 1979;40:704-718. [Medline]
Deutscher S, Rockette HE, Krishnaswami V. Evaluation of habitual excessive alcohol consumption on myocardial infarction risk in coronary disease patients. Am Heart J 1984;108:988-995. [CrossRef][Medline]
Fraser GE, Upsdell M. Alcohol and other discriminants between cases of sudden death and myocardial infarction. Am J Epidemiol 1981;114:462-476. [Free Full Text]
Hennekens CH. Alcohol. In: Kaplan NM, Stamler J, eds. Prevention of coronary heart disease: practical management of the risk factors. Philadelphia: W.B. Saunders, 1983:130-8.
Hennekens CH, Rosner B, Cole DS. Daily alcohol consumption and fatal coronary heart disease. Am J Epidemiol 1978;107:196-200. [Free Full Text]
Ross RK, Paganini-Hill A, Mack TM, Arthur M, Henderson BE. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet 1981;1:858-860. [CrossRef][Medline]
Klatsky AL, Friedman GD, Siegelaub AB. Alcohol consumption before myocardial infarction: results from the Kaiser-Permanente epidemiologic study of myocardial infarction. Ann Intern Med 1974;81:294-301.
Stason WB, Neff RK, Miettinen OS, Jick H. Alcohol consumption and nonfatal myocardial infarction. Am J Epidemiol 1976;104:603-608. [Free Full Text]
Rosenberg L, Slone D, Shapiro S, Kaufman DW, Miettinen OS, Stolley PD. Alcoholic beverages and myocardial infarction in young women. Am J Public Health 1981;71:82-85. [Free Full Text]
Gordon T, Kannel WB. Drinking habits and cardiovascular disease: the Framingham Study. Am Heart J 1983;105:667-673. [CrossRef][Medline]
Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: relationship to biologic and lifestyle characteristics. Am J Epidemiol 1984;119:653-666. [Free Full Text]
Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988;319:267-273. [Abstract]
Cullen K, Stenhouse NS, Wearne KL. Alcohol and mortality in the Busselton study. Int J Epidemiol 1982;11:67-70. [Free Full Text]
Colditz GA, Branch LG, Lipnick RJ, et al. Moderate alcohol and decreased cardiovascular mortality in an elderly cohort. Am Heart J 1985;109:886-889. [CrossRef][Medline]
Dyer AR, Stamler J, Paul O, et al. Alcohol consumption and 17-year mortality in the Chicago Western Electric Company study. Prev Med 1980;9:78-90. [CrossRef][Medline]
Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol 1986;124:481-489. [Free Full Text]
Gordon T, Doyle JT. Drinking and coronary heart disease: the Albany Study. Am Heart J 1985;110:331-334. [CrossRef][Medline]
Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338:464-468. [CrossRef][Medline]
Moore RD, Pearson TA. Moderate alcohol consumption and coronary artery disease: a review. Medicine (Baltimore) 1986;65:242-267. [Medline]
Castelli WP, Doyle JT, Gordon T, et al. Alcohol and blood lipids: the cooperative lipoprotein phenotyping study. Lancet 1977;2:153-155. [CrossRef][Medline]
Hulley SB, Gordon S. Alcohol and high-density lipoprotein cholesterol: causal inference from diverse study designs. Circulation 1981;64:Suppl III:III-57.
Ernst N, Fisher M, Smith W, et al. The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption: the Lipid Research Clinics Program Prevalence Study. Circulation 1980;62:Suppl IV:IV-41.
Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992;85:910-915. [Free Full Text]
Suh I, Shaten BJ, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol: the Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med 1992;116:881-887.
Glueck CJ, Hogg E, Allen C, Gartside PS. Effects of alcohol ingestion on lipids and lipoproteins in normal men: isocaloric metabolic studies. Am J Clin Nutr 1980;33:2287-2293. [Free Full Text]
Hartung GH, Foreyt JP, Mitchell RE, Mitchell JG, Reeves RS, Gotto AM Jr. Effect of alcohol intake on high-density lipoprotein cholesterol levels in runners and inactive men. JAMA 1983;249:747-750. [Free Full Text]
Barr DP, Russ EM, Eder HA. Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions. Am J Med 1951;11:480-493. [CrossRef][Medline]
Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975;1:16-19. [CrossRef][Medline]
Castelli WP, Doyle JT, Gordon T, et al. HDL cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation 1977;55:767-772. [Free Full Text]
Gordon T, Castelli WP, Hjortland MC, Kannell WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977;62:707-714. [CrossRef][Medline]
Gofman JW, Young W, Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation 1966;34:679-697. [Free Full Text]
Miller NE, Hammett F, Saltissi S, et al. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. BMJ 1981;282:1741-1744.
Ballantyne FC, Clark RS, Simpson HS, Ballantyne D. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. Metabolism 1982;31:433-437. [CrossRef][Medline]
Haffner SM, Applebaum-Bowden D, Wahl PW, et al. Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase: effects of smoking, alcohol, and adiposity. Arteriosclerosis 1985;5:169-177. [Free Full Text]
Diehl AK, Fuller JH, Mattock MB, Salter AM, el-Gohari R, Keen H. The relationship of high density lipoprotein subfractions to alcohol consumption, other lifestyle factors, and coronary heart disease. Atherosclerosis 1988;69:145-153. [CrossRef][Medline]
Haskell WL, Camargo C Jr, Williams PT, et al. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. N Engl J Med 1984;310:805-810. [Abstract]
Buring JE, O'Connor GT, Goldhaber SZ, et al. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation 1992;85:22-29. [Free Full Text]
Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991;325:373-381. [Abstract]
Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65. [Free Full Text]
Giovannucci E, Colditz G, Stampfer MJ, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 1991;133:810-817. [Free Full Text]
Haynes SG, Levine S, Scotch N, Feinleib M, Kannel WB. The relationship of psychosocial factors to coronary heart disease in the Framingham study. I. Methods and risk factors. Am J Epidemiol 1978;107:362-383. [Free Full Text]
Lipid Research Clinics population studies data book. Vol. I. The Prevalence Study. Bethesda, Md.: Dept. of Health and Human Services, 1980:28-81. (DHHS publication no. (NIH) 80-1527.)
Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982;28:1379-1388. [Free Full Text]
National Heart and Lung Institute. Manual of laboratory operations: Lipid Research Clinics Program. Vol. 1. Lipid and lipoprotein analysis. Bethesda, Md.: National Heart and Lung Institute, 1974:51-9. (DHEW publication no. (NIH) 75-628.)
Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206-1223. [Abstract]
Tall AR, Blum CB, Forester GP, Nelson CA. Changes in the distribution and composition of plasma high density lipoproteins after ingestion of fat. J Biol Chem 1982;257:198-207. [Free Full Text]
Musliner TA, Garner PA, Henderson LO, Herbert PN. Radioimmunoassay of apolipoprotein a-ii. Arteriosclerosis 1982;2:160-169. [Free Full Text]
Blum CB, Aron L, Sciacca R. Radioimmunoassay studies of human apolipoprotein E. J Clin Invest 1980;66:1240-1250.
Schlesselman JJ. Case control studies: design, conduct, analysis. New York: Oxford University Press, 1982.
Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, Calif.: Lifetime Learning, 1982.
Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet 1988;2:1267-1273. [Medline]
Criqui MH, Cowan LD, Tyroler HA, et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results from the Lipid Research Clinics Follow-up Study. Am J Epidemiol 1987;126:629-637. [Free Full Text]
Avogaro P, Cazzolato G, Belussi F, Bittolo Bon G. Altered apoprotein composition of HDL2 and HDL3 in chronic alcoholics. Artery 1982;10:317-328. [Medline]
Dai WS, LaPorte RE, Hom DL, et al. Alcohol consumption and high density lipoprotein cholesterol concentration among alcoholics. Am J Epidemiol 1985;122:620-627. [Free Full Text]
Danielsson B, Ekman R, Fex G, et al. Changes in plasma high density lipoproteins in chronic male alcoholics during and after abuse. Scand J Clin Lab Invest 1978;38:113-119. [Medline]
Taskinen MR, Valimaki M, Nikkila EA, Kuusi T, Ehnholm C, Ylikahri R. High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal. Metabolism 1982;31:1168-1174. [CrossRef][Medline]
Valimaki M, Nikkila EA, Taskinen M-R, Ylikahri R. Rapid decrease in high density lipoprotein subfractions and postheparin plasma lipase activities after cessation of chronic alcohol intake. Atherosclerosis 1986;59:147-153. [CrossRef][Medline]
Taylor KG, Carter TJ, Valente AJ, Wright AD, Smith JH, Matthews KA. Sex differences in the relationships between obesity, alcohol consumption and cigarette smoking and serum lipid and apolipoprotein concentrations in a normal population. Atherosclerosis 1981;38:11-18. [CrossRef][Medline]
Camargo CA Jr, Williams PT, Vranizan KM, Albers JJ, Wood PD. The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II: a controlled study. JAMA 1985;253:2854-2857. [Free Full Text]
Fraser GE, Anderson JT, Foster N, Goldberg R, Jacobs D, Blackburn H. The effect of alcohol on serum high density lipoprotein (HDL): a controlled experiment. Atherosclerosis 1983;46:275-286. [CrossRef][Medline]
Dohadwala, M. M., Vita, J. A.
(2009). Grapes and Cardiovascular Disease. J. Nutr.
139: 1788S-1793S
[Abstract][Full Text]
White, S. L., Polkinghorne, K. R., Cass, A., Shaw, J. E., Atkins, R. C., Chadban, S. J.
(2009). Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant
24: 2464-2472
[Abstract][Full Text]
Djousse, L., Lee, I-M., Buring, J. E., Gaziano, J. M.
(2009). Alcohol Consumption and Risk of Cardiovascular Disease and Death in Women: Potential Mediating Mechanisms. Circulation
120: 237-244
[Abstract][Full Text]
Kerr, D., Penfold, S., Zouwail, S., Thomas, P., Begley, J.
(2009). The influence of liberal alcohol consumption on glucose metabolism in patients with type 1 diabetes: a pilot study. QJM
102: 169-174
[Abstract][Full Text]
Beulens, J. W.J., Rimm, E. B., Hu, F. B., Hendriks, H. F.J., Mukamal, K. J.
(2008). Alcohol Consumption, Mediating Biomarkers, and Risk of Type 2 Diabetes Among Middle-Aged Women. Diabetes Care
31: 2050-2055
[Abstract][Full Text]
Ferns, G., Keti, V.
(2008). HDL-cholesterol modulation and its impact on the management of cardiovascular risk. Ann Clin Biochem
45: 122-128
[Abstract][Full Text]
Wakabayashi, I.
(2008). Associations of Alcohol Drinking and Cigarette Smoking with Serum Lipid Levels in Healthy Middle-Aged Men. Alcohol Alcohol
0: agn005v1-agn005
[Abstract][Full Text]
Kaneda, K., Miyamae, M., Sugioka, S., Okusa, C., Inamura, Y., Domae, N., Kotani, J., Figueredo, V. M.
(2008). Sevoflurane Enhances Ethanol-Induced Cardiac Preconditioning Through Modulation of Protein Kinase C, Mitochondrial KATP Channels, and Nitric Oxide Synthase, in Guinea Pig Hearts. Anesth. Analg.
106: 9-16
[Abstract][Full Text]
Sacanella, E., Vazquez-Agell, M., Mena, M. P., Antunez, E., Fernandez-Sola, J., Nicolas, J. M., Lamuela-Raventos, R. M, Ros, E., Estruch, R.
(2007). Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial. Am. J. Clin. Nutr.
86: 1463-1469
[Abstract][Full Text]
Vazquez-Agell, M., Sacanella, E., Tobias, E., Monagas, M., Antunez, E., Zamora-Ros, R., Andres-Lacueva, C., Lamuela-Raventos, R. M., Fernandez-Sola, J., Nicolas, J. M., Estruch, R.
(2007). Inflammatory Markers of Atherosclerosis Are Decreased after Moderate Consumption of Cava (Sparkling Wine) in Men with Low Cardiovascular Risk. J. Nutr.
137: 2279-2284
[Abstract][Full Text]
Sung, K.-C., Kim, S. H., Reaven, G. M.
(2007). Relationship Among Alcohol, Body Weight, and Cardiovascular Risk Factors in 27,030 Korean Men. Diabetes Care
30: 2690-2694
[Abstract][Full Text]
Kloner, R. A., Rezkalla, S. H.
(2007). To Drink or Not to Drink? That Is the Question. Circulation
116: 1306-1317
[Abstract][Full Text]
Singh, I. M., Shishehbor, M. H., Ansell, B. J.
(2007). High-Density Lipoprotein as a Therapeutic Target: A Systematic Review. JAMA
298: 786-798
[Abstract][Full Text]
Schafer, C., Parlesak, A., Eckoldt, J., Bode, C., Bode, J. C., Marz, W., Winkler, K.
(2007). Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers. J. Lipid Res.
48: 1550-1558
[Abstract][Full Text]
Mukamal, K. J., Mackey, R. H., Kuller, L. H., Tracy, R. P., Kronmal, R. A., Mittleman, M. A., Siscovick, D. S.
(2007). Alcohol Consumption and Lipoprotein Subclasses in Older Adults. J. Clin. Endocrinol. Metab.
92: 2559-2566
[Abstract][Full Text]
Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Del Parigi, A., Baldassarre, G., Scapicchio, P., Scafato, E., Amodio, M., Capurso, A., Panza, F., For the Italian Longitudinal Study on Aging Workin,
(2007). Alcohol consumption, mild cognitive impairment, and progression to dementia. Neurology
68: 1790-1799
[Abstract][Full Text]
Jonsen, A., Gullstrand, B., Guner, N., Bengtsson, A.A., Nived, O., Truedsson, L., Sturfelt, G.
(2007). Genetically determined mannan-binding lectin deficiency is of minor importance in determining susceptibility to severe infections and vascular organ damage in systemic lupus erythematosus. Lupus
16: 245-253
[Abstract]
Wong, D. R., Willett, W. C., Rimm, E. B.
(2007). Smoking, Hypertension, Alcohol Consumption, and Risk of Abdominal Aortic Aneurysm in Men. Am J Epidemiol
165: 838-845
[Abstract][Full Text]
Gueye, A. S., Chelamcharla, M., Baird, B. C., Nguyen, C., Tang, H., Barenbaum, A. L., Koford, J. K., Shihab, F., Goldfarb-Rumyantzev, A. S.
(2007). The association between recipient alcohol dependency and long-term graft and recipient survival. Nephrol Dial Transplant
22: 891-898
[Abstract][Full Text]
Erdman, J. W. Jr., Balentine, D., Arab, L., Beecher, G., Dwyer, J. T., Folts, J., Harnly, J., Hollman, P., Keen, C. L., Mazza, G., Messina, M., Scalbert, A., Vita, J., Williamson, G., Burrowes, J.
(2007). Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J. Nutr.
137: 718S-737S
[Abstract][Full Text]
Kurth, T., Everett, B. M., Buring, J. E., Kase, C. S., Ridker, P. M., Gaziano, J. M.
(2007). Lipid levels and the risk of ischemic stroke in women. Neurology
68: 556-562
[Abstract][Full Text]
Djousse, L., Gaziano, J. M.
(2007). Alcohol Consumption and Risk of Heart Failure in the Physicians' Health Study I. Circulation
115: 34-39
[Abstract][Full Text]
Rippe, J. M., Angelopoulos, T. J., Zukley, L.
(2007). The Rationale for Intervention to Reduce the Risk of Coronary Heart Disease. AMERICAN JOURNAL OF LIFESTYLE MEDICINE
1: 10-19
[Abstract]
Everett, B. M., Kurth, T., Buring, J. E., Ridker, P. M.
(2006). The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women. J Am Coll Cardiol
48: 2235-2242
[Abstract][Full Text]
Gigleux, I., Gagnon, J., St-Pierre, A., Cantin, B., Dagenais, G. R., Meyer, F., Despres, J.-P., Lamarche, B.
(2006). Moderate Alcohol Consumption Is More Cardioprotective in Men with the Metabolic Syndrome. J. Nutr.
136: 3027-3032
[Abstract][Full Text]
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L.
(2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Circulation
113: e873-e923
[Abstract][Full Text]
Reid, M. C., Van Ness, P. H., Hawkins, K. A., Towle, V., Concato, J., Guo, Z.
(2006). Light to moderate alcohol consumption is associated with better cognitive function among older male veterans receiving primary care.. J Geriatr Psychiatry Neurol
19: 98-105
[Abstract]
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L.
(2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Stroke
37: 1583-1633
[Abstract][Full Text]
Gazzieri, D., Trevisani, M., Tarantini, F., Bechi, P., Masotti, G., Gensini, G. F., Castellani, S., Marchionni, N., Geppetti, P., Harrison, S.
(2006). Ethanol dilates coronary arteries and increases coronary flow via transient receptor potential vanilloid 1 and calcitonin gene-related peptide. Cardiovasc Res
70: 589-599
[Abstract][Full Text]
Wright, C. B., Elkind, M. S.V., Rundek, T., Boden-Albala, B., Paik, M. C., Sacco, R. L.
(2006). Alcohol Intake, Carotid Plaque, and Cognition: The Northern Manhattan Study. Stroke
37: 1160-1164
[Abstract][Full Text]
Eigenbrodt, M. L, Fuchs, F. D, Couper, D. J, Goff, D. C Jr, Sanford, C. P., Hutchinson, R. G, Bursac, Z.
(2006). Changing drinking pattern does not influence health perception: a longitudinal study of the atherosclerosis risk in communities study.. J. Epidemiol. Community Health
60: 345-350
[Abstract][Full Text]
Englund Ogge, L., Brohall, G., Behre, C. J., Schmidt, C., Fagerberg, B.
(2006). Alcohol Consumption in Relation to Metabolic Regulation, Inflammation, and Adiponectin in 64-Year-Old Caucasian Women: A population-based study with a focus on impaired glucose regulation. Diabetes Care
29: 908-913
[Abstract][Full Text]
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S. C., Katzan, I., Kelly-Hayes, M., Kenton, E. J., Marks, M., Schwamm, L. H., Tomsick, T.
(2006). Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.. Circulation
113: e409-e449
[Abstract][Full Text]
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S. C., Katzan, I., Kelly-Hayes, M., Kenton, E. J., Marks, M., Schwamm, L. H., Tomsick, T.
(2006). Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.. Stroke
37: 577-617
[Abstract][Full Text]
Elkind, M. S.V., Sciacca, R., Boden-Albala, B., Rundek, T., Paik, M. C., Sacco, R. L.
(2006). Moderate Alcohol Consumption Reduces Risk of Ischemic Stroke: The Northern Manhattan Study. Stroke
37: 13-19
[Abstract][Full Text]
Ellison, R. C.
(2005). Importance of Pattern of Alcohol Consumption. Circulation
112: 3818-3819
[Full Text]
Ruhm, C. J
(2005). Commentary: Mortality increases during economic upturns. Int J Epidemiol
34: 1206-1211
[Full Text]
Ashen, M. D., Blumenthal, R. S.
(2005). Low HDL Cholesterol Levels. NEJM
353: 1252-1260
[Full Text]
Freiberg, M. S., Samet, J. H.
(2005). Alcohol and Coronary Heart Disease: The Answer Awaits a Randomized Controlled Trial. Circulation
112: 1379-1381
[Full Text]
Lindeman, R. D., Wayne, S. J., Baumgartner, R. N., Garry, P. J.
(2005). Cognitive Function in Drinkers Compared to Abstainers in The New Mexico Elder Health Survey. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
60: 1065-1070
[Abstract][Full Text]
Vogel, J. H.K., Bolling, S. F., Costello, R. B., Guarneri, E. M., Krucoff, M. W., Longhurst, J. C., Olshansky, B., Pelletier, K. R., Tracy, C. M., Vogel, R. A., Vogel, R. A., Abrams, J., Anderson, J. L., Bates, E. R., Brodie, B. R., Grines, C. L., Danias, P. G., Gregoratos, G., Hlatky, M. A., Hochman, J. S., Kaul, S., Lichtenberg, R. C., Lindner, J. R., O'Rourke, R. A., Pohost, G. M., Schofield, R. S., Shubrooks, S. J., Tracy, C. M., Winters, W. L. Jr
(2005). Integrating Complementary Medicine Into Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). J Am Coll Cardiol
46: 184-221
[Full Text]
Lucas, D. L., Brown, R. A., Wassef, M., Giles, T. D.
(2005). Alcohol and the Cardiovascular System: Research Challenges and Opportunities. J Am Coll Cardiol
45: 1916-1924
[Abstract][Full Text]
Schaeffner, E. S., Kurth, T., de Jong, P. E., Glynn, R. J., Buring, J. E., Gaziano, J. M.
(2005). Alcohol Consumption and the Risk of Renal Dysfunction in Apparently Healthy Men. Arch Intern Med
165: 1048-1053
[Abstract][Full Text]
Szmitko, P. E., Verma, S.
(2005). Antiatherogenic potential of red wine: clinician update. Am. J. Physiol. Heart Circ. Physiol.
288: H2023-H2030
[Abstract][Full Text]
Otiniano, M. E., Du, X. L., Maldonado, M. R., Ray, L., Markides, K.
(2005). Effect of Metabolic Syndrome on Heart Attack and Mortality in Mexican-American Elderly Persons: Findings of 7-Year Follow-Up From the Hispanic Established Population for the Epidemiological Study of the Elderly. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
60: 466-470
[Abstract][Full Text]
Espeland, M. A., Gu, L., Masaki, K. H., Langer, R. D., Coker, L. H., Stefanick, M. L., Ockene, J., Rapp, S. R., for the Women's Health Initiative Memory Study,
(2005). Association between Reported Alcohol Intake and Cognition: Results from the Women's Health Initiative Memory Study. Am J Epidemiol
161: 228-238
[Abstract][Full Text]
Mahabir, S., Leitzmann, M. F., Virtanen, M. J., Virtamo, J., Pietinen, P., Albanes, D., Taylor, P. R.
(2005). Prospective Study of Alcohol Drinking and Renal Cell Cancer Risk in a Cohort of Finnish Male Smokers. Cancer Epidemiol. Biomarkers Prev.
14: 170-175
[Abstract][Full Text]
Djousse, L., Pankow, J. S, Arnett, D. K, Eckfeldt, J. H, Myers, R. H, Ellison, R C.
(2004). Apolipoprotein E polymorphism modifies the alcohol-HDL association observed in the National Heart, Lung, and Blood Institute Family Heart Study. Am. J. Clin. Nutr.
80: 1639-1644
[Abstract][Full Text]
Freiberg, M. S., Cabral, H. J., Heeren, T. C., Vasan, R. S., Curtis Ellison, R.
(2004). Alcohol Consumption and the Prevalence of the Metabolic Syndrome in the U.S.: A cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care
27: 2954-2959
[Abstract][Full Text]
Vliegenthart, R., Oei, H.-H. S., van den Elzen, A. P. M., van Rooij, F. J. A., Hofman, A., Oudkerk, M., Witteman, J. C. M.
(2004). Alcohol Consumption and Coronary Calcification in a General Population. Arch Intern Med
164: 2355-2360
[Abstract][Full Text]
Niroomand, F, Hauer, O, Tiefenbacher, C P, Katus, H A, Kuebler, W
(2004). Influence of alcohol consumption on restenosis rate after percutaneous transluminal coronary angioplasty and stent implantation. Heart
90: 1189-1193
[Abstract][Full Text]
Badia, E., Sacanella, E., Fernandez-Sola, J., Nicolas, J. M., Antunez, E., Rotilio, D., de Gaetano, G., Urbano-Marquez, A., Estruch, R.
(2004). Decreased tumor necrosis factor-induced adhesion of human monocytes to endothelial cells after moderate alcohol consumption. Am. J. Clin. Nutr.
80: 225-230
[Abstract][Full Text]
Aguilar, D., Skali, H., Moye, L. A., Lewis, E. F., Gaziano, J. M., Rutherford, J. D., Hartley, L. H., Randall, O. S., Geltman, E. M., Lamas, G. A., Rouleau, J. L., Pfeffer, M. A., Solomon, S. D.
(2004). Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction. J Am Coll Cardiol
43: 2015-2021
[Abstract][Full Text]
Cuevas, A., Miquel, J. F., Reyes, M. S., Zanlungo, S., Nervi, F.
(2004). Diet as a Risk Factor for Cholesterol Gallstone Disease. J. Am. Coll. Nutr.
23: 187-196
[Abstract][Full Text]
Tawakol, A., Omland, T., Creager, M. A.
(2004). Direct effect of ethanol on human vascular function. Am. J. Physiol. Heart Circ. Physiol.
286: H2468-H2473
[Abstract][Full Text]
Zairis, M N, Ambrose, J A, Lyras, A G, Thoma, M A, Psarogianni, P K, Psaltiras, P G, Kardoulas, A D, Bibis, G P, Pissimissis, E G, Batika, P C, DeVoe, M C, Prekates, A A, Foussas, S G
(2004). C Reactive protein, moderate alcohol consumption, and long term prognosis after successful coronary stenting: four year results from the GENERATION study. Heart
90: 419-424
[Abstract][Full Text]
Park, H. S., Oh, S. W., Cho, S.-I., Choi, W. H., Kim, Y. S.
(2004). The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol
33: 328-336
[Abstract][Full Text]
Malinski, M. K., Sesso, H. D., Lopez-Jimenez, F., Buring, J. E., Gaziano, J. M.
(2004). Alcohol Consumption and Cardiovascular Disease Mortality in Hypertensive Men. Arch Intern Med
164: 623-628
[Abstract][Full Text]
Charchar, F. J., Tomaszewski, M., Lacka, B., Zakrzewski, J., Zukowska-Szczechowska, E., Grzeszczak, W., Dominiczak, A. F.
(2004). Association of the Human Y Chromosome with Cholesterol Levels in the General Population. Arterioscler. Thromb. Vasc. Bio.
24: 308-312
[Abstract][Full Text]
Zee, R. Y.L., Ridker, P. M., Cook, N. R.
(2004). Prospective Evaluation of the Alcohol Dehydrogenase {gamma}1/{gamma}2 Gene Polymorphism and Risk of Stroke. Stroke
35
: e39-e42
[Abstract][Full Text]
Bohm, M., Rosenkranz, S., Laufs, U.
(2004). Alcohol and red wine: impact on cardiovascular risk. Nephrol Dial Transplant
19: 11-16
[Full Text]
Ghiselli, G., Chen, J., Kaou, M., Hallak, H., Rubin, R.
(2003). Ethanol Inhibits Fibroblast Growth Factor-Induced Proliferation of Aortic Smooth Muscle Cells. Arterioscler. Thromb. Vasc. Bio.
23: 1808-1813
[Abstract][Full Text]
Klatsky, A. L., Friedman, G. D., Armstrong, M. A., Kipp, H.
(2003). Wine, Liquor, Beer, and Mortality. Am J Epidemiol
158: 585-595
[Abstract][Full Text]
Chung, B.-H., Doran, S., Liang, P., Osterlund, L., Cho, B. S., Oster, R. A, Darnell, B., Franklin, F.
(2003). Alcohol-mediated enhancement of postprandial lipemia: a contributing factor to an increase in plasma HDL and a decrease in risk of cardiovascular disease. Am. J. Clin. Nutr.
78: 391-399
[Abstract][Full Text]
Mennen, L. I, de Courcy, G. P., Guilland, J.-C., Ducros, V., Zarebska, M., Bertrais, S., Favier, A., Hercberg, S., Galan, P.
(2003). Relation between homocysteine concentrations and the consumption of different types of alcoholic beverages: the French Supplementation with Antioxidant Vitamins and Minerals Study. Am. J. Clin. Nutr.
78: 334-338
[Abstract][Full Text]
Leitzmann, M. F, Tsai, C.-J., Stampfer, M. J, Rimm, E. B, Colditz, G. A, Willett, W. C, Giovannucci, E. L
(2003). Alcohol consumption in relation to risk of cholecystectomy in women. Am. J. Clin. Nutr.
78: 339-347
[Abstract][Full Text]
Sesso, H. D, Gaziano, J M., Liu, S., Buring, J. E
(2003). Flavonoid intake and the risk of cardiovascular disease in women. Am. J. Clin. Nutr.
77: 1400-1408
[Abstract][Full Text]
Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., Heymsfield, S. B.
(2003). The Metabolic Syndrome: Prevalence and Associated Risk Factor Findings in the US Population From the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med
163: 427-436
[Abstract][Full Text]
Albert, M. A., Glynn, R. J., Ridker, P. M
(2003). Alcohol Consumption and Plasma Concentration of C-Reactive Protein. Circulation
107: 443-447
[Abstract][Full Text]
Nakanishi, N., Suzuki, K., Tatara, K.
(2003). Alcohol Consumption and Risk for Development of Impaired Fasting Glucose or Type 2 Diabetes in Middle-Aged Japanese Men. Diabetes Care
26: 48-54
[Abstract][Full Text]
Kalmijn, S., van Boxtel, M. P. J., Verschuren, M. W. M., Jolles, J., Launer, L. J.
(2002). Cigarette Smoking and Alcohol Consumption in Relation to Cognitive Performance in Middle Age. Am J Epidemiol
156: 936-944
[Abstract][Full Text]
Tall, A. R.
(2002). Exercise to Reduce Cardiovascular Risk -- How Much Is Enough?. NEJM
347: 1522-1524
[Full Text]
Ferry-Dumazet, H., Garnier, O., Mamani-Matsuda, M., Vercauteren, J., Belloc, F., Billiard, C., Dupouy, M., Thiolat, D., Kolb, J. P., Marit, G., Reiffers, J., Mossalayi, M.D.
(2002). Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis
23: 1327-1333
[Abstract][Full Text]
Tessari, P., Bruttomesso, D., Pianta, A., Vettore, M., Zanetti, M., Kiwanuka, E., Iori, E.
(2002). Effects of wine intake on postprandial plasma amino acid and protein kinetics in type 1 diabetes. Am. J. Clin. Nutr.
75: 856-866
[Abstract][Full Text]
Pataki, T., Bak, I., Kovacs, P., Bagchi, D., Das, D. K, Tosaki, A.
(2002). Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. Am. J. Clin. Nutr.
75: 894-899
[Abstract][Full Text]
Dulli, D. A.
(2002). Alcohol, Ischemic Stroke, and Lessons From a Negative Study. Stroke
33: 890-891
[Full Text]
Djousse, L., Ellison, R. C., Beiser, A., Scaramucci, A., D'Agostino, R. B., Wolf, P. A.
(2002). Alcohol Consumption and Risk of Ischemic Stroke: The Framingham Study. Stroke
33: 907-912
[Abstract][Full Text]
Ruidavets, J-B, Ducimetiere, P, Arveiler, D, Amouyel, P, Bingham, A, Wagner, A, Cottel, D, Perret, B, Ferrieres, J
(2002). Types of alcoholic beverages and blood lipids in a French population. J. Epidemiol. Community Health
56: 24-28
[Abstract][Full Text]
van der Gaag, M. S., van Tol, A., Vermunt, S. H. F., Scheek, L. M., Schaafsma, G., Hendriks, H. F. J.
(2001). Alcohol consumption stimulates early steps in reverse cholesterol transport. J. Lipid Res.
42: 2077-2083
[Abstract][Full Text]
Hines, L M, Rimm, E B
(2001). Moderate alcohol consumption and coronary heart disease: a review. Postgrad. Med. J.
77: 747-752
[Full Text]
Mukamal, K. J., Jadhav, P. P., D'Agostino, R. B., Massaro, J. M., Mittleman, M. A., Lipinska, I., Sutherland, P. A., Matheney, T., Levy, D., Wilson, P. W.F., Ellison, R. C., Silbershatz, H., Muller, J. E., Tofler, G. H.
(2001). Alcohol Consumption and Hemostatic Factors: Analysis of the Framingham Offspring Cohort. Circulation
104: 1367-1373
[Abstract][Full Text]
Gu, J.-W., Elam, J., Sartin, A., Li, W., Roach, R., Adair, T. H.
(2001). Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulate angiogenesis. Am. J. Physiol. Regul. Integr. Comp. Physiol.
281: R365-R372
[Abstract][Full Text]
Freedman, J. E., Parker, C. III, Li, L., Perlman, J. A., Frei, B., Ivanov, V., Deak, L. R., Iafrati, M. D., Folts, J. D.
(2001). Select Flavonoids and Whole Juice From Purple Grapes Inhibit Platelet Function and Enhance Nitric Oxide Release. Circulation
103: 2792-2798
[Abstract][Full Text]
Abramson, J. L., Williams, S. A., Krumholz, H. M., Vaccarino, V.
(2001). Moderate Alcohol Consumption and Risk of Heart Failure Among Older Persons. JAMA
285: 1971-1977
[Abstract][Full Text]
Corella, D., Tucker, K., Lahoz, C., Coltell, O., Cupples, L A., Wilson, P. W., Schaefer, E. J, Ordovas, J. M
(2001). Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. Am. J. Clin. Nutr.
73: 736-745
[Abstract][Full Text]
Cole, S. R, Kawachi, I., Liu, S., Gaziano, J M., Manson, J. E, Buring, J. E, Hennekens, C. H
(2001). Time urgency and risk of non-fatal myocardial infarction. Int J Epidemiol
30: 363-369
[Abstract][Full Text]
Hines, L. M., Stampfer, M. J., Ma, J., Gaziano, J. M., Ridker, P. M., Hankinson, S. E., Sacks, F., Rimm, E. B., Hunter, D. J.
(2001). Genetic Variation in Alcohol Dehydrogenase and the Beneficial Effect of Moderate Alcohol Consumption on Myocardial Infarction. NEJM
344: 549-555
[Abstract][Full Text]
Tegos, T. J., Kalodiki, E., Sabetai, M. M., Nicolaides, A. N.
(2001). The Genesis of Atherosclerosis and Risk Factors: A Review. ANGIOLOGY
52: 89-98
[Abstract]
Sharrett, A. R., Heiss, G., Chambless, L. E., Boerwinkle, E., Coady, S. A., Folsom, A. R., Patsch, W.
(2001). Metabolic and Lifestyle Determinants of Postprandial Lipemia Differ From Those of Fasting Triglycerides : The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. Vasc. Bio.
21: 275-281
[Abstract][Full Text]
Gross, E. R., Gare, M., Toller, W. G., Kersten, J. R., Warltier, D. C., Pagel, P. S.
(2001). Ethanol Enhances the Functional Recovery of Stunned Myocardium Independent of KATP Channels in Dogs. Anesth. Analg.
92: 299-305
[Abstract][Full Text]
Malarcher, A. M., Giles, W. H., Croft, J. B., Wozniak, M. A., Wityk, R. J., Stolley, P. D., Stern, B. J., Sloan, M. A., Sherwin, R., Price, T. R., Macko, R. F., Johnson, C. J., Earley, C. J., Buchholz, D. W., Kittner, S. J.
(2001). Alcohol Intake, Type of Beverage, and the Risk of Cerebral Infarction in Young Women. Stroke
32: 77-83
[Abstract][Full Text]
De Oliveira e Silva, E. R., Foster, D., McGee Harper, M., Seidman, C. E., Smith, J. D., Breslow, J. L., Brinton, E. A.
(2000). Alcohol Consumption Raises HDL Cholesterol Levels by Increasing the Transport Rate of Apolipoproteins A-I and A-II. Circulation
102: 2347-2352
[Abstract][Full Text]
Pignatelli, P., Pulcinelli, F. M, Celestini, A., Lenti, L., Ghiselli, A., Gazzaniga, P. P., Violi, F.
(2000). The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am. J. Clin. Nutr.
72: 1150-1155
[Abstract][Full Text]
